Retractions, AI, and the Risks of Biomedical Misinformation

Retractions are a serious threat to biomedical research

In the high-stakes world of biomedical research, where published findings can shape clinical practice, policy decisions, and even drug approvals, the presence of retracted literature is not just an academic problem, it’s a public health concern. When flawed, fabricated, or irreproducible studies are left unchecked in the scientific ecosystem, they continue to misinform downstream research, meta-analyses, clinical guidelines, and ultimately, patient care.

Retractions aren’t rare, either. According to Retraction Watch, retractions have been steadily rising over the last decade. Still, many retracted studies continue to circulate in the literature without any obvious indication that they’ve been pulled. 

AI-powered biomedical searching and retractions

There are dozens, maybe even hundreds, of AI tools that promise to revolutionize biomedical literature searching. These tools claim to make life easier for clinicians and researchers by surfacing “the best” evidence quickly.

Unfortunately, these AI tools likely struggle with reliably flagging retracted articles. None of these tools appear to cross-reference the Retraction Watch Database, even though it’s one of the most comprehensive and up-to-date sources of retraction data.

The result? Users could end up citing, summarizing, or even basing treatment decisions on debunked science and the AI tools they trusted helped them do it.

Putting three AI search assistant tools to the test

To assess whether current AI-powered tools can reliably detect and communicate retracted biomedical research, we ran a small, but telling test using a recently retracted article:

Wu, S. Y., Sharma, S., Wu, K., Tyagi, A., Zhao, D., Deshpande, R. P., & Watabe, K. (2021). Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions. Breast Cancer Research, 23, 1-16.

This article was retracted on May 12, 2025.

We located this article through the Retraction Watch Database, a critical resource for identifying retracted papers. We then tested how three popular AI tools responded when we searched for this article: 1) SciSpace, 2) Consensus, and 3) Elicit/

Baseline: Publisher and PubMed got it right

The article is clearly marked as retracted on both the publisher’s website (BMC, part of Springer Nature) and in PubMed. On BMC’s site, the article is branded with a bold red banner indicating that it has been retracted, and it links directly to the retraction notice.

In PubMed, the article’s retraction status is labelled. There’s a large red “Retracted Article” warning at the top of the article record. 

With Third Iron’s LibKey Nomad browser extension installed, the retraction warning also appeared directly in the search results list, providing an extra layer of protection.

These platforms demonstrate that it is possible to handle retractions clearly and transparently. But what happens when you try to search with an AI-powered tool?

1) SciSpace: No retraction flag, no awareness

SciSpace has gained traction for its AI-enabled “Papers” database and its Chat AI for article summarization. We searched for the retracted article using the Papers function. The article was retrieved with no indication that it had been retracted.

The PDF version offered by SciSpace appeared to be the original, unretracted version of the paper — there was no watermark or retraction notice. This likely occurred because SciSpace stored an earlier version of the file and does not dynamically update with retraction metadata or new PDFs.

When we asked the SciSpace Chat if the article had been retracted, the reply was: “Sorry, this is not discussed in the paper.” In other words, the AI agent only read the text of the article and had no external awareness of its retraction status.

SciSpace also failed to locate or return the associated Retraction Note (PMID: 40355962), which was published in the same journal.

2) Consensus: Accurate link, but no warning

Consensus is designed to help users quickly identify answers to scientific questions by ranking statements from published articles.

The article was returned in a basic search, and no indication of its retracted status was provided. The PDF link routed to the publisher’s version, which is good practice. Since BMC properly flags retractions, users landing on that page would see the retraction banner and be able to access the Retraction Note. While Consensus did not flag the article as retracted in its own search interface or metadata, it did link out to a source that did.

3) Elicit: Somewhat better!

Elicit offers two formats for reviewing articles: a plain-text view and a PDF view. When we searched for the retracted article via Elicit’s “Find Papers” tool, the results were mixed.

The article summary did not indicate that the paper had been retracted. The plain text view contained the word “RETRACTED” throughout the body text. Elicit also linked to a newer version of the article PDF that had the retraction stamp clearly watermarked across every page.

Lessons learned: We need accountability and standards

Users skimming article summaries, relying on search results, or using data extraction tables generated by AI tools might still miss the retraction unless they click deeper into the article itself. This is especially concerning in evidence synthesis workflows, where tools like Elicit auto-populate summary tables with study characteristics and conclusions—often without indicating the article has been retracted.

If AI is going to play a meaningful role in evidence retrieval and synthesis, it needs to be held to a higher standard. At a minimum, AI tools used in biomedical contexts must:

  • Flag retracted articles clearly and automatically
  • Cross-reference multiple retraction sources, including Retraction Watch
  • Date-stamp and cite their information sources transparently
  • Allow users to report errors or omissions easily

Until the current AI tools ecosystem improves, here are some tips to protect yourself and your team:

  • Always cross-check critical articles in the Retraction Watch Database or in PubMed
  • Use reference managers (like Zotero or EndNote) that integrate with PubMed and allow for manual annotations of retracted status
  • Avoid relying solely on AI summaries or ranking algorithms, especially for high-stakes research

It’s also worth noting that all the tools we tested (SciSpace, Consensus, and Elicit) are paid products and are effectively marketed as intelligent research assistants. Yet their inconsistent handling of retracted literature highlights the need for human-level vetting and cross-referencing.

In practice, this can take significantly more time than a traditional search if you’re trying to be thorough. Instead of accelerating research, these tools often introduce a false sense of efficiency, making it easy to miss red flags that would be obvious in a well-curated, librarian-led search process. The MSK Library team can help you navigate retraction risks, validate sources, and choose the right tools for your research. Connect with us today

 

Choosing Between Extraction 1 and Extraction 2 in Covidence

Here’s a tip for getting the most out of data extraction in Covidence.

For background, the MSK Library has an institutional account to Covidence, an online software platform used for systematic and other related reviews. Covidence offers teams a collaborative space to screen, appraise, and extract data from articles, and our institutional account means anyone at MSK can use this platform for their review projects.

Once you’re within the Covidence page for your review, you’ll see there are four stages below Review Summary, with Extraction at the end. When you click on Settings to the right of Review Summary, you’ll have the option of selecting between Extraction 1 and Extraction 2.

Both extraction options offer a customizable data extraction template, so which to choose?

Covidence offers the FAQ: How to decide when to use Extraction 1 vs Extraction 2.

  • Extraction 1 is designed for intervention reviews with a standardized PICO(T) structure, as it offers a structured format for organized data collection, which makes meta-analysis easier. This structure allows it to automatically fill in data extraction fields with suggestions you can review. Results can be exported to CSV, Excel, and RevMan.
  • Extraction 2 offers an unstructured format for flexible data collection and is fully customizable. It doesn’t offer automated extraction suggestions and only exports to CSV.

Learn more about data extraction and templates for these two options in the Covidence Knowledge Base. If you prefer to be hands-on, Covidence offers a demo review, and you can test both extraction options there before choosing which one is best for your project.

Learn more about reviews, Covidence, and the way MSK librarians can support you within the guide to our Systematic Review Service.

Effective July 1, 2025 – New NIH Public Access Policy

It was announced on April 30, 2025, that the 2024 NIH Public Access Policy, originally planned to come into effect at the end of 2025 will now be effective as of July 1, 2025.

A key difference between the 2008 and the new 2024 NIH Public Access Policy has to do with how quickly a full-text PMC version of the research article is required to be made publicly available.

In the 2008 version of the policy, the PMC copy had up to 12 months after official publication to become publicly available. The 2024 version of the policy removes the 12-month publisher embargo option and requires the article’s PMC version to become available immediately upon official publication. The new policy will apply to all NIH-funded research articles submitted for journal publication starting on July 1st.

From: https://www.nih.gov/about-nih/who-we-are/nih-director/statements/accelerating-access-research-results-new-implementation-date-2024-nih-public-access-policy

“While the 2008 Policy allowed for an up to 12-month delay before such articles were required to be made publicly available, in 2024, NIH revised the Public Access Policy to remove the embargo period so that researchers, students, and members of the public have rapid access to these findings.”

From: NOT-OD-25-101- Revision: Notice of Updated Effective Date for the 2024 NIH Public Access Policy:

“NIH’s default position is maximum transparency regarding research and research findings. This Notice updates the Effective Date of the 2024 NIH Public Access Policy, NOT-OD-25-047to July 1, 2025 at which time it will replace the 2008 Public Access Policy. All other aspects of the Policy remain the same.“

From: NOT-OD-25-047 – 2024 NIH Public Access Policy:

Regarding submission to PubMed Central, compliance with the Policy may be achieved through either:

  • Submission of the electronic version of the Author Accepted Manuscript to PubMed Central upon its acceptance for publication, for public availability without embargo upon the Official Date of Publication, or
  • Submission of the Final Published Article to PubMed Central from journals or publishers with formal agreements with NLM, upon the Official Date of Publication, for public availability without embargo.

Learn more about how to comply with the NIH Pubic Access Policy or Ask Us your questions.